Edge Therapeutics (EDGE) News Today → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free EDGE Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock AnalysisCompetitorsHeadlinesSocial MediaStock AnalysisCompetitorsHeadlinesSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineOptimistic Buy Rating for Dyne Therapeutics Backed by Promising DYNE-101 Drug Efficacy Datamarkets.businessinsider.com - May 3 at 8:47 PMCorcept Therapeutics Inc (CORT) Q1 2024 Earnings Call Transcript Highlights: Strong Growth Amid ...uk.finance.yahoo.com - May 2 at 3:50 PM500Newswire, LLC: CB Therapeutics Unveils Revolutionary Breakthroughs in Crafting Pharmaceutical-Grade Cannabinoids and Analoguesfinanznachrichten.de - May 2 at 10:49 AMCB Therapeutics Unveils Revolutionary Breakthroughs in Crafting Pharmaceutical-Grade Cannabinoids and Analoguesfinance.yahoo.com - May 2 at 10:49 AMKelonia Therapeutics to Participate in Upcoming Scientific Conferencesfinance.yahoo.com - May 2 at 10:49 AMAsimov Achieves 10x Improvement in Lentiviral Production, Launches New Stable Cell Line Development Servicefinance.yahoo.com - April 30 at 2:38 AMEVOX THERAPEUTICS LIMITED: Evox Therapeutics Names Co-Founder Dr. Per Lundin as Chief Executive Officerfinanznachrichten.de - April 29 at 4:37 PMEvox Therapeutics Names Co-Founder Dr. Per Lundin as Chief Executive Officermarkets.businessinsider.com - April 29 at 8:53 AMRactigen Therapeutics Announces FDA Approval for RAG-01, a First-in-Class saRNA Therapy for BCG-Unresponsive NMIBCfinance.yahoo.com - April 26 at 12:43 PMMundipharma to acquire rezafungin assets from Cidara Therapeuticsmsn.com - April 26 at 12:43 PMFDA approves Utility Therapeutics’ Pivya tablets for UTIsmsn.com - April 26 at 12:43 PMBiologic Therapeutics Drugs Market Size Projections Exhibit a CAGR of 12.2%%, Likely to Attain a Value of USD 1485.0 Billion by 2033finance.yahoo.com - April 25 at 8:34 AMCutting-edge RM6 Million Laboratory Opens at UMMC to Advance Cancer Treatmentmarkets.businessinsider.com - April 24 at 2:31 AMRed Arrow Therapeutics Inc. closes $4.5M Seed Extension roundfinance.yahoo.com - April 23 at 2:08 AMVect-Horus Publication in Pharmaceutics Outlines How Vectors Can Improve Delivery of Therapeutics to Organs and Tumorsuk.finance.yahoo.com - April 22 at 2:04 PMIpsen and Skyhawk Therapeutics announce RNA targeting research collaboration in rare neurological diseasesmarkets.businessinsider.com - April 22 at 9:03 AMPeptide Therapeutics Market Projected to Reach $57.97 billion by 2030 - Exclusive Report by 360iResearchfinance.yahoo.com - April 19 at 1:34 PMMaintaining the Edge: Argenx’s Hold Rating Amidst Rising Competition and Promising Therapy Resultsmarkets.businessinsider.com - April 18 at 8:17 PMPanasonic and Shinobi Therapeutics Partner to Develop Efficient and Cost-Effective iPS Cell Therapy Manufacturing Technologyfinance.yahoo.com - April 18 at 10:15 AMMyeloid Therapeutics to Participate in Chardan's 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summitfinance.yahoo.com - April 15 at 7:05 PMGastrointestinal Therapeutics and Diagnostics: Propelling Global Markets with Cutting-Edge Technologies by BCC Research LLCfinance.yahoo.com - April 15 at 9:05 AMHow cutting-edge therapies—like Ozempic—are changing the drug-pricing landscapemsn.com - April 14 at 9:57 AMPrelude Therapeutics Unveils Promising Cancer Treatment Advances at AACR Meetingmsn.com - April 11 at 1:50 AMBuy Vafseo's Approval: A New Chapter For Akebia Therapeutics In Anemia Managementseekingalpha.com - April 4 at 7:43 PMMyeloid Therapeutics to Showcase In Vivo CAR Data and its Diverse mRNA Platform at AACRfinance.yahoo.com - April 4 at 9:42 AMUS Stocks Edge Lower; Private Employment Tops Viewsbenzinga.com - April 3 at 10:21 AMNeighbors on edge after dog owner dead blocks away from Washington Avenue: 'Honestly kind of scared'msn.com - April 3 at 12:18 AMAccelerating New Molecule Discovery: Rakovina Therapeutics AI Integrationfinance.yahoo.com - April 2 at 2:18 PMUPDATE 1-Verve Therapeutics pauses enrollment in early-stage gene therapy study for high cholesterol levelssg.finance.yahoo.com - April 2 at 9:17 AMToronto Stocks Edge Lower; Ballard Power Rises on Fuel-Cell Ordermarketwatch.com - April 1 at 1:15 PMGPCR Therapeutics Announces Publication in PNAS Using Cutting Edge Spectroscopy to Detect GPCR Heteromers on Live Cancer Cellsfinance.yahoo.com - April 1 at 1:15 PMCrispr Therapeutics: Upcoming Catalysts May Validate The Bull Thesis And Force A Change In Plansseekingalpha.com - March 30 at 3:53 AMGlobal Metastatic Melanoma Therapeutics Market Anticipates Robust Growth with New Therapeutic Developmentsuk.finance.yahoo.com - March 28 at 12:35 AMIs Indaptus Therapeutics (NASDAQ:INDP) In A Good Position To Invest In Growth?finance.yahoo.com - March 27 at 9:33 AMCompanies Like Context Therapeutics (NASDAQ:CNTX) Could Be Quite Riskyfinance.yahoo.com - March 27 at 9:33 AMQ4 2023 Mink Therapeutics Inc Earnings Callau.finance.yahoo.com - March 22 at 12:34 AMMirador Therapeutics Launches to Accelerate the Next Generation of Precision Medicines for Immune-mediated Diseasesfinance.yahoo.com - March 21 at 7:50 AMPhaxiam Therapeutics S.A.: PHAXIAM Announces 2023 Full-Year Results and Provides Business Updatefinanznachrichten.de - March 20 at 4:48 PMTempo Therapeutics Secures Series A Financing to Advance Cutting-Edge Tissue Scaffold Products into Clinical Trialsfinance.yahoo.com - March 19 at 10:13 PMContineum Therapeutics Seeks $150 Million IPO For MS Treatmentsseekingalpha.com - March 19 at 12:11 PMTelum Therapeutics appoints Dr. Subhendu Basu as CEOfinanznachrichten.de - March 19 at 7:10 AMBrenig Therapeutics Presented New Data for the Best-in-Class LRRK2 Inhibitor Targeting Parkinson's Disease at the ACS Spring 2024 Conferencefinance.yahoo.com - March 18 at 4:09 PMMonoclonal Antibody (mABs) Therapeutics Market Worth $497.5 billion | MarketsandMarketsfinanznachrichten.de - March 15 at 1:14 PMPioneering Protein Design A New Frontier in COVID-19 Therapeuticsmsn.com - March 15 at 8:14 AMLeading-Edge Technologies, Data and Insights: Bio-IT World Conference & Expo Highlights the Drivers of Precision Medicine Innovationfinance.yahoo.com - March 14 at 10:36 AMPrime Therapeutics and Capital Rx Enter Into Transformative Strategic Alliancefinance.yahoo.com - March 13 at 8:30 AMPromising Future for Kymera Therapeutics: Analyst Endorses ‘Buy’ on Innovative Protein Degradation Compoundsmarkets.businessinsider.com - March 11 at 7:47 AMPromontory Therapeutics Enrolls 109 Patients in Prostate Cancer Studyfinance.yahoo.com - March 8 at 12:04 PMKyverna Therapeutics and Stanford University Agree to Evaluate KYV-101 in Patients with Non-Relapsing and Progressive Forms of Multiple Sclerosisfinance.yahoo.com - March 7 at 9:02 PMFierce Medtech Names Genesis Therapeutics a "Fierce 15" Company of 2023finance.yahoo.com - March 6 at 6:09 PM Get Edge Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for EDGE and its competitors with MarketBeat's FREE daily newsletter. Email Address Never use this word on your phone (FBI could be watching) (Ad)This report sent a chill down my spine. Turns out, as part of their Jan. 6th investigation, the Feds are flagging Americans who typed these ordinary words as part of their banking transactions... Watch my unredacted video about what I think is coming next right here EDGE Media Mentions By Week EDGE Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EDGE News Sentiment▼0.000.42▲Average Medical News Sentiment EDGE News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EDGE Articles This Week▼87▲EDGE Articles Average Week Get Edge Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for EDGE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Rezolute News Today Nuvectis Pharma News Today Relmada Therapeutics News Today CytomX Therapeutics News Today Adagene News Today Cellectar Biosciences News Today Emergent BioSolutions News Today DiaMedica Therapeutics News Today Abeona Therapeutics News Today Immunic News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EDGE) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersCould Your Accounts Be Frozen?Allegiance GoldAutomatic Income (from home)Awesomely, LLCUrgent Nvidia WarningAltimetryForget Nvidia. This is the future of AIPorter & CompanyHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceThe asset beating inflation by 4xColonial MetalsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Edge Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
